The Truth About Nicotine and Vaping: INNCO's Perspective

Dec.01.2022
The Truth About Nicotine and Vaping: INNCO's Perspective
Misinformation hinders progress on ending smoking. Nicotine is not the problem, it's the smoke. Safe alternatives for smokers exist.

For many years, nicotine has been demonized by anti-smoking "experts" to discourage smoking. INNCO argues that while quitting smoking should be a shared goal, it is unethical to distort the truth in order to achieve it.


To make matters worse, this practice continues, effectively sentencing smokers to an unnecessary death without providing them an escape route.


Nicotine itself does not cause cancer, cardiovascular or pulmonary diseases. The harm comes from the smoke produced by burning cigarettes. Therefore, it is necessary to promote the use of safer nicotine substitutes to replace toxic tobacco products and save the lives of smokers. Failing to do so is tantamount to involuntary manslaughter.


Several months ago, Dr. Sara Kayat appeared on ITV's "This Morning" show alongside hosts Alison Hammond and Dermot O'Leary to issue unverified warnings about nicotine electronic cigarettes (commonly known as "e-cigarettes"). Dr. Kayat stated, "There are many other issues starting to surface...the most concerning is lung damage. There's a condition called popcorn lung. This is an inflammatory lung disease that may occur from using e-cigarettes.


The International Network of Nicotine Consumer Organizations (INNCO) stated that there is no evidence to support the claim made and presenting such misinformation can have an adverse effect on efforts to quit smoking. When healthcare professionals make assumptions based on incomplete investigations and present them as facts, it creates fear and unnecessary concern, ultimately preventing people from making informed decisions about their health and well-being. Preventing smokers from switching to safer alternatives such as nicotine e-cigarettes is akin to causing a public health tragedy.


2FIRSTS will continue to cover this topic and provide updates on the "2FIRSTS APP". Scan the QR code below to download the app.


This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.

U.S. vape firms appeal Mississippi synthetic-nicotine ban, citing FDA authority preemption
U.S. vape firms appeal Mississippi synthetic-nicotine ban, citing FDA authority preemption
A coalition of U.S. vape industry groups has appealed a Mississippi law banning the sale of e-cigarette products containing synthetic nicotine, arguing the statute effectively conditions sales on FDA authorization and unlawfully encroaches on federal regulatory authority. The law took effect in July 2025 and has already begun to be enforced.
Dec.17 by 2FIRSTS.ai
After Export Tax Rebates Go to Zero: How China’s E-Cigarette Supply Chain Is Being Reshaped, According to 2Firsts Research
After Export Tax Rebates Go to Zero: How China’s E-Cigarette Supply Chain Is Being Reshaped, According to 2Firsts Research
China’s e-cigarette industry is adjusting to a major policy shift. From April 1, 2026, China will scrap the 13% export VAT rebate on e-cigarette products, a move affecting manufacturers centered in Shenzhen. Industry participants told 2Firsts the change is forcing a reassessment of pricing and capacity, with competition shifting toward cash flow resilience, regulatory compliance, and multi-location strategies.
Industry Insight
Jan.16
5th Circuit Reviews FDA’s Compliance on Small-Business Impact of Vape Rule
5th Circuit Reviews FDA’s Compliance on Small-Business Impact of Vape Rule
A Fifth Circuit panel expressed doubts about whether the U.S. Food and Drug Administration complied with the Regulatory Flexibility Act when issuing its 2021 final rule on premarket tobacco product applications. Vape companies argued the FDA relied on outdated and inaccurate economic data, while the government said the challenged requirements stem from the Tobacco Control Act.
Dec.03 by 2FIRSTS.ai
Bangladesh High Court Questions Legality of BEZA’s Approval for Philip Morris Nicotine Pouch Factory
Bangladesh High Court Questions Legality of BEZA’s Approval for Philip Morris Nicotine Pouch Factory
The High Court in Bangladesh has asked government bodies to explain why the approval granted to Philip Morris to establish a nicotine pouch factory should not be deemed illegal. Petitioners argue the decision contradicts existing policies and a 2016 Appellate Division ruling that restricts new tobacco-related enterprises. Authorities have ten days to respond.
Nov.20 by 2FIRSTS.ai
Organigram Global Appoints Former BAT Global Head of Strategy James Yamanaka as Chief Executive Officer
Organigram Global Appoints Former BAT Global Head of Strategy James Yamanaka as Chief Executive Officer
Organigram Global has named James Yamanaka, previously Global Head of Strategy at British American Tobacco (BTI), as its new CEO. His appointment is expected to take effect around January 15, 2026, and he will also join the company’s board. Yamanaka brings more than 20 years of strategic and managerial experience from roles across Europe and Asia at BTI.
Nov.26
WHO MOP4 Focuses on Justice and Prosecution to Combat Illicit Tobacco Trade
WHO MOP4 Focuses on Justice and Prosecution to Combat Illicit Tobacco Trade
The Fourth Meeting of the Parties (MOP4) to the Protocol to Eliminate Illicit Trade in Tobacco Products opened in Geneva on November 24, 2025. With 60 Parties participating, the meeting focuses on strengthening legal action and international cooperation to combat illicit trade, which accounts for about 11% of the global tobacco market and costs governments billions in lost tax revenue.
Nov.25 by 2FIRSTS.ai